Search

Your search keyword '"Papillomavirus infections -- Care and treatment"' showing total 742 results
Start Over Descriptor "Papillomavirus infections -- Care and treatment"
742 results on '"Papillomavirus infections -- Care and treatment"'

1. New Squamous Cell Carcinoma Study Findings Have Been Reported by Investigators at Harvard Medical School (Radiation Therapy for Hpv-positive Oropharyngeal Squamous Cell Carcinoma: an Astro Clinical Practice Guideline)

Subjects
Practice guidelines (Medicine) -- Health aspects, Papillomavirus infections -- Care and treatment, Radiation -- Health aspects, Squamous cell carcinoma -- Care and treatment, Radiotherapy -- Health aspects, Physical fitness -- Health aspects, Evidence-based medicine -- Health aspects, Health, Harvard University. Harvard Medical School
Abstract

2024 OCT 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Oncology - Squamous Cell Carcinoma have been presented. According [...]

Published
2024

2. Monitoring of Cell-free Human Papillomavirus DNA in Metastatic or Recurrent Cervical Cancer: Clinical Significance and Treatment Implications

Subjects
Care and treatment, Cancer treatment, Papillomavirus -- Care and treatment, Cancer genetics -- Care and treatment, Cervical cancer -- Care and treatment, Papillomavirus infections -- Care and treatment, Women's health, Recurrence (Disease) -- Care and treatment, DNA, Cancer metastasis -- Care and treatment, Women -- Health aspects, Metastasis -- Care and treatment, Diseases -- Relapse, Papillomaviruses -- Care and treatment, Cancer -- Care and treatment -- Genetic aspects
Abstract

2024 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2024

3. Researchers from First Affiliated Hospital of Xi'an Jiaotong University Report Recent Findings in Aminolevulinic Acid (5-aminolevulinic acid induced photodynamic reactions in diagnosis and therapy for female lower genital tract diseases)

Subjects
Diseases -- Care and treatment -- China, Papillomavirus infections -- Care and treatment, Physical fitness, Health
Abstract

2024 AUG 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in aminolevulinic acid. According to news originating from [...]

Published
2024

4. Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation

Subjects
Women -- Health aspects, DNA -- Health aspects, Papillomavirus infections -- Care and treatment, Cancer -- Care and treatment -- Genetic aspects, Cervical cancer -- Care and treatment, Health, Women's issues/gender studies
Abstract

2024 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2024

5. Investigators at Italian Institute of Technology Report Findings in Theranostics (In Vivo Combined Photoacoustic Imaging and Photothermal Treatment of Hpv-negative Head and Neck Carcinoma With Nir-responsive Non-persistent Plasmon ...)

Subjects
Technical institutes -- Reports, Papillomavirus infections -- Care and treatment, Squamous cell carcinoma -- Care and treatment, Physical fitness -- Reports, Health
Abstract

2024 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Theranostics. According to [...]

Published
2024

6. Data from University of Medicine and Pharmacy Provide New Insights into Cervical Cancer (The Role of Lymph Node Downstaging Following Neoadjuvant Treatment in a Group of Patients with Advanced Stage Cervical Cancer)

Subjects
Oncology, Experimental, Women -- Health aspects, Cancer -- Adjuvant treatment -- Research, Cancer patients -- Care and treatment, Papillomavirus infections -- Care and treatment, Cervical cancer -- Care and treatment, Pharmacy, Health, Women's issues/gender studies
Abstract

2024 JUN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on cervical cancer. According to news reporting out of Bucharest, [...]

Published
2024

7. Hookipa Pharma reports updated Phase 2 HB-200 combination data at ASCO 2024

Subjects
Papillomavirus infections -- Care and treatment, Clinical trials, Business, News, opinion and commentary
Abstract

HOOKIPA Pharma announced updated results from its Phase 2 clinical trial of HB-200 in combination with pembrolizumab in patients with recurrent/metastatic human papillomavirus 16 positive head and neck cancer. The [...]

Published
2024

8. ALX Oncology announces initiation of Phase 2 trial in patients with HPVOC

Subjects
Papillomavirus infections -- Care and treatment, Business, News, opinion and commentary
Abstract

ALX Oncology Holdings announced the initiation of a Phase 2 investigator-sponsored trial of neoadjuvant radiation and evorpacept, a next-generation CD47 blocker, in combination KEYTRUDA in patients with previously untreated and [...]

Published
2024

9. Hookipa Pharma announces pivotal phase 2/3 trial design for HB-200 in combination with pembrolizumab

Subjects
United States. Food and Drug Administration, Papillomavirus infections -- Care and treatment, Squamous cell carcinoma -- Care and treatment, Clinical trials, Pharmaceuticals and cosmetics industries
Abstract

Hookipa Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced its final pivotal phase 2/3 trial design for HB-200 in combination with [...]

Published
2024

10. University Hospital Researcher Discusses Findings in Cancer (Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center)

Subjects
Oncology, Experimental -- Reports -- Analysis, Women -- Health aspects, Temsirolimus -- Analysis -- Reports, Papillomavirus infections -- Care and treatment, Cancer -- Genetic aspects -- Research, Health, Women's issues/gender studies
Abstract

2024 MAR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on cancer. According to news originating from Munich, Germany, by [...]

Published
2024

11. Investigators from Lanzhou University Report New Data on Papillomavirus Infections (Photodynamic Therapy With Tbzpy Regulates the Pi3k/akt and Endoplasmic Reticulum Stress-related Perk/eif2a Pathways In Hela Cells)

Subjects
Endoplasmic reticulum -- Physiological aspects, Cancer -- Photochemotherapy, Papillomavirus infections -- Care and treatment, Photochemotherapy -- Methods -- Patient outcomes -- Evaluation, Photosensitizing compounds -- Dosage and administration -- Testing, Stress (Physiology) -- Evaluation, HeLa cells -- Physiological aspects -- Health aspects, Health
Abstract

2024 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Tumor Virus Infections - Papillomavirus Infections. According [...]

Published
2024

12. Probiotic effect of trichloroacetic acid on cervicovaginal microbiota in cervical intraepithelial neoplasia: A pilot study

Subjects
Women -- Health aspects, Microbiota (Symbiotic organisms), Papillomavirus infections -- Care and treatment, Cervix dysplasia -- Care and treatment, Health, Women's issues/gender studies
Abstract

2024 JAN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2024

13. Data from Polish Academy of Sciences Advance Knowledge in Ovarian Neoplasms (Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms)

Subjects
Women -- Health aspects, Tumors -- Care and treatment, Papillomavirus infections -- Care and treatment, MicroRNA -- Analysis, Health, Women's issues/gender studies
Abstract

2024 JAN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on ovarian neoplasms. According to news reporting originating from Lodz, [...]

Published
2024

14. Study Findings on Human Papillomavirus 16 Discussed by Researchers at Kasetsart University (The Inhibitory Effect of Kerra[superscript]TM, KS[superscript]TM, and Minoza[superscript]TM on Human Papillomavirus Infection and Cervical Cancer)

Subjects
Papillomavirus infections -- Care and treatment, Medicine, Botanic -- Research, Cervical cancer -- Care and treatment, Therapeutics, Experimental, Medicine, Herbal -- Research, Health
Abstract

2024 JAN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on human papillomavirus 16 are discussed in a new report. [...]

Published
2024

15. People's Hospital of Guangxi Zhuang Autonomous Region Researchers Have Provided New Data on Cervical Intraepithelial Neoplasia (Advances in ablative treatment for human papillomavirus related cervical pre-cancer lesions)

Subjects
Women -- Health aspects, Papillomavirus infections -- Care and treatment, Cervical cancer -- Care and treatment, Cervix dysplasia -- Care and treatment, Health, Women's issues/gender studies
Abstract

2024 JAN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A new study on cervical intraepithelial neoplasia is now available. According to news originating [...]

Published
2024

16. Rice University Researchers Highlight Research in Cervical Cancer (A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care)

Subjects
Oncology, Experimental, Women -- Health aspects, DNA, Papillomavirus infections -- Care and treatment, Cervical cancer -- Care and treatment, Cancer -- Research, Health, Women's issues/gender studies, Rice University
Abstract

2023 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Researchers detail new data in cervical cancer. According to news reporting from Rice University [...]

Published
2023

17. Study Data from Birjand University of Medical Sciences Provide New Insights into Papillomavirus Infections [Prevalence of Oral Human Papillomavirus (HPV) in Patients with Genital HPV Infections: A Systematic Review and Meta-analysis]

Subjects
Medical research, Medicine, Experimental, Sexually transmitted diseases -- Care and treatment, Papillomaviruses -- Care and treatment, Papillomavirus infections -- Care and treatment, Prevalence studies (Epidemiology), Infection -- Care and treatment, Health
Abstract

2024 OCT 18 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on papillomavirus infections have been published. According to news originating [...]

Published
2024

19. Data on Papillomatosis Detailed by a Researcher at Pauls Stradins Clinical University Hospital (Successful bevacizumab therapy in a 25-year-old patient with recurrent respiratory papillomatosis)

Subjects
Medical research, Medicine, Experimental, Homeopathy -- Materia medica and therapeutics, Papillomavirus infections -- Care and treatment, Therapeutics, Vaccines
Abstract

2024 SEP 25 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- New research on papillomatosis is the subject of a new report. According to news originating [...]

Published
2024

20. Data on Oropharyngeal Cancer Published by a Researcher at Johns Hopkins University (Lower survival for surgical treatment of HPV-related oropharynx cancer at community cancer centers)

Subjects
Oncology, Experimental -- Reports, Throat cancer -- Care and treatment, Papillomavirus infections -- Care and treatment, Cancer -- Research
Abstract

2024 SEP 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on oropharyngeal cancer is now available. According to news reporting originating from [...]

Published
2024

21. Nykode Therapeutics ASA: Nykode Therapeutics Announces Strategic Repositioning of VB10.16 to Focus on Locally Advanced Cervical Cancer and Recurrent Metastatic Head and Neck Cancer

Subjects
Metastasis -- Care and treatment, Diseases -- Relapse, Papillomavirus infections -- Care and treatment, Cancer -- Genetic aspects, Cervical cancer -- Care and treatment, Cancer vaccines, Head and neck cancer -- Care and treatment, Business, international
Abstract

Oslo: Nykode Therapeutics ASA has issued the following news release: Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced [...]

Published
2024

22. Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Subjects
Inovio Pharmaceuticals Inc., Biotechnology industry, Papillomavirus infections -- Care and treatment, Drugs, Business, News, opinion and commentary
Abstract

Data reviewed complies with standards that would be used to evaluate an EU Marketing Authorization Application PLYMOUTH MEETING, Pa., July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company [...]

Published
2024

23. RECOMMENDATIONS FOR THE TREATMENT OF TRICHOMONAS VAGINALIS, MYCOPLASMA GENITALIUM, CANDIDA ALBICANS, BACTERIAL VAGINOSIS AND HUMAN PAPILLOMAVIRUS ( ANOGENITAL WARTS)

Subjects
Infection control, Vaginosis -- Care and treatment, Drug resistance in microorganisms -- Care and treatment, Papillomavirus infections -- Care and treatment, Antibiotics, Warts -- Care and treatment, News, opinion and commentary
Abstract

GENEVA, Switzerland -- The following information was released by the World Health Organization: Overview These guidelines focus on the treatment for infections caused by Trichomonas vaginalis, Mycoplasma genitalium and Candida [...]

Published
2024

24. SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors

Subjects
United States. Food and Drug Administration, T cells -- Health aspects, Tumors -- Care and treatment, Immunotherapy -- Health aspects, Papillomavirus infections -- Care and treatment, Drug approval -- Health aspects, Clinical trials -- Health aspects, Business, News, opinion and commentary
Abstract

SINGAPORE, June 30, 2024 /PRNewswire/-- SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and [...]

Published
2024

25. Bicara Therapeutics Reports Updated Interim Phase 1/1b Data of Ficerafusp Alfa (BCA101) in 1L HPV-negative Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Subjects
Papillomavirus infections -- Care and treatment, Squamous cell carcinoma -- Care and treatment, Business, Business, international
Abstract

First-in-class bifunctional EGFR/TGF- inhibitor, ficerafusp alfa, in combination with pembrolizumab has demonstrated clinically meaningful anti-tumor activity and significant improvement over standard of care in HNSCC with at least 12 months [...]

Published
2024

26. Antiva Biosciences Announces Formation of Scientific and Development Advisory Board

Subjects
Gilead Sciences Inc., Biological products industry -- Health aspects, Drug discovery -- Health aspects, Papillomavirus infections -- Care and treatment, General interest, News, opinion and commentary
Abstract

REDWOOD CITY: Antiva Biosciences, Inc. has issued the following news release: Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of high-risk infections and pre-cancerous lesions caused [...]

Published
2024

27. Antiva Biosciences Announces Formation of Scientific and Development Advisory Board

Subjects
Gilead Sciences Inc., Biological products industry -- Health aspects, Women -- Health aspects, Homeopathy -- Materia medica and therapeutics, Papillomavirus infections -- Care and treatment, Therapeutics -- Health aspects, Business, News, opinion and commentary
Abstract

Board Consists of Distinguished Thought Leaders with Clinical Expertise Spanning Women's Health and Virology, Combined with Successful Drug Development and Commercialization Experience REDWOOD CITY, Calif., June 13, 2024 /PRNewswire/ -- [...]

Published
2024

28. PDS announces preliminary study results of subset of patients in VERSATILE-002

Subjects
Merck & Company Inc. -- Reports, T cells -- Analysis -- Reports, Papillomavirus infections -- Care and treatment, Squamous cell carcinoma -- Care and treatment, Pharmaceutical industry -- Reports -- Analysis, Business, News, opinion and commentary, Keytruda (Medication) -- Reports
Abstract

PDS Biotechnology announced immune response data from a preliminary analysis of a subset of patients in VERSATILE-002, the Phase 2 clinical trial evaluating the safety and efficacy of PDS0101 in [...]

Published
2023

29. PDS Biotechnology announces data on PDS0101 combined with chemoradiotherapy

Subjects
Biotechnology, Papillomavirus infections -- Care and treatment, Cervical cancer -- Care and treatment, Business, News, opinion and commentary
Abstract

PDS Biotechnology announced data demonstrating lead candidate PDS0101 in combination with standard-of-care chemoradiotherapy was associated with a rapid decline in human papillomavirus circulating cell-free DNA, a potential predictive biomarker of [...]

Published
2023

30. Cue Biopharma completes patient enrollment in phase 1b study of CUE-101 in combo with Keytruda in first line refractory/metastatic HPV+ head and neck cancer

Subjects
United States. Food and Drug Administration, Biological products industry -- Product development, Medical research, Medicine, Experimental, Papillomavirus infections -- Care and treatment, Squamous cell carcinoma -- Care and treatment, Clinical trials, Pharmaceuticals and cosmetics industries, Keytruda (Medication) -- Product development
Abstract

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, announced that it has completed patient enrollment in its phase 1 clinical trial (NCT03978689) evaluating CUE-101, the company's lead interleukin 2 (IL-2)-based biologic [...]

Published
2023

31. PDS Biotechnology reschedules KOL roundtable on HNSCC treatments

Subjects
Biotechnology, Biotechnology industry, Papillomavirus infections -- Care and treatment, Squamous cell carcinoma -- Care and treatment, Business, News, opinion and commentary
Abstract

PDS Biotechnology Corporation announced that its Key Opinion Leader Roundtable on Addressing Current and Future Treatments for Recurrent/Metastatic Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma and the Potential Application [...]

Published
2023

32. US FDA grants breakthrough therapy designation to Inovio's INO-3107 to treat recurrent respiratory papillomatosis

Subjects
United States. Food and Drug Administration, Papillomavirus infections -- Care and treatment, Pharmaceuticals and cosmetics industries
Abstract

Inovio, a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, announced that the US Food and [...]

Published
2023

33. WHO: Off-track progress in Africa could kill 70,000 cervical cancer patients

Subjects
Cancer patients -- Care and treatment, Papillomavirus infections -- Care and treatment, Cervical cancer -- Care and treatment, Vaccines, Environmental issues, Regional focus/area studies, World Health Organization
Abstract

India, Sept. 4 -- 26 countries have introduced HPV vaccine, but just 31% girls under 15 received its first dose in 2022 in the African region Around 70,000 cervical cancer [...]

Published
2023

34. Reports Outline Human Papillomavirus Study Findings from Huazhong University of Science and Technology (HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-3)

Subjects
Medical research, Medicine, Experimental, Papillomaviruses -- Care and treatment, Diseases -- Care and treatment, Papillomavirus infections -- Care and treatment, Health
Abstract

2024 AUG 30 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in human papillomavirus. According to news reporting originating from [...]

Published
2024

35. SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors

Subjects
United States. Food and Drug Administration, T cells, Tumors -- Care and treatment, Immunotherapy, Papillomavirus infections -- Care and treatment, Drug approval, Clinical trials, Biomedical engineering, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious [...]

Published
2024

36. Bicara Therapeutics Reports Updated Interim Phase 1/1b Data of Ficerafusp Alfa BCA101 in 1L HPV-negative Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma HNSCC

Subjects
Medical research, Medicine, Experimental, Papillomavirus infections -- Care and treatment, Squamous cell carcinoma -- Care and treatment, Transforming growth factors, Monoclonal antibodies, Epidermal growth factor, Business, Health, Health care industry
Abstract

2024 JUL 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Bicara Therapeutics, a clinical-stage biotechnology company developing transformative bifunctional therapies for patients with solid tumors, [...]

Published
2024

37. ASTRO issues clinical guideline on radiation therapy for patients with HPV-related throat cancer

Subjects
Practice guidelines (Medicine) -- Health aspects, Papillomavirus infections -- Care and treatment, Squamous cell carcinoma -- Care and treatment, Radiation -- Health aspects, Cancer -- Care and treatment, Vaccines -- Health aspects, Radiotherapy -- Health aspects, Health
Abstract

2024 JUL 3 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- ARLINGTON, Va., - The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline [...]

Published
2024

39. ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer

Subjects
Medical research, Medicine, Experimental, Immunotherapy, Papillomavirus infections -- Care and treatment, Radiation, Clinical trials, Cancer -- Care and treatment, Radiotherapy, Banking, finance and accounting industries, Business
Abstract

SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ('ALX Oncology' or 'the Company') (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 [...]

Published
2024

40. Naveris Announces Launch of Phase II Clinical Study in MRD+ Head and Neck Cancer

Subjects
Oncology, Experimental, Papillomavirus infections -- Care and treatment, Clinical trials, Cancer -- Research, Head and neck cancer -- Care and treatment, Business, Business, international, Memorial Sloan-Kettering Cancer Center
Abstract

NavDx to be used to identify eligible patients with molecular relapse after definitive treatment for HPV16+ head and neck squamous cell cancer and to monitor throughout study WALTHAM, Mass. -- [...]

Published
2024

41. RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients

Subjects
Immunotherapy, Papillomavirus infections -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

- Confirmed objective response rate (ORR) of 15.6% in all patients regardless of PD-L1 or HPV status - Confirmed ORR of 17.4% in subset of patients with PD-L1+ disease - [...]

Published
2024

43. LGBT People Can Face Unique Skin Health Challenges

Subjects
Sexually transmitted diseases -- Care and treatment, Papillomavirus infections -- Care and treatment, Skin -- Health aspects, Health
Abstract

Byline: Ernie Mundell HealthDay Reporter TUESDAY, March 12, 2024 (HealthDay News) -- Gay and bisexual people, as well as those undergoing gender transition, could face unique dermatological issues, an expert [...]

Published
2024

44. PDS announces efficacy threshold achieved for VERSATILE-002 Phase 2 trial

Subjects
Merck & Company Inc. -- Product development, Medical research, Medicine, Experimental, Papillomavirus infections -- Care and treatment, Clinical trials, Pharmaceutical industry -- Product development, Business, News, opinion and commentary
Abstract

PDS Biotechnology announced the Company achieved the threshold for efficacy as per investigator assessment in Stage 2 of the VERSATILE-002 Phase 2 clinical trial investigating PDS0101 in combination with Merck's [...]

Published
2023

45. Precigen announces Phase 1 data of OTS PRGN-2009 AdenoVerse

Subjects
Papillomavirus infections -- Care and treatment, Business, News, opinion and commentary
Abstract

Precigen presented positive clinical data from the Phase 1 study of the off-the-shelf, OTS, PRGN-2009 AdenoVerse immunotherapy alone and in combination with an investigational anti-PDL1/TGF-Beta Trap checkpoint inhibitor in patients [...]

Published
2023

49. Reports from University of Texas Describe Recent Advances in Cancer (Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers)

Subjects
Women -- Health aspects, Papillomaviruses -- Care and treatment, Papillomavirus infections -- Care and treatment, Clinical trials, Cancer -- Care and treatment, Vaccines -- Product development, Health, Women's issues/gender studies, University of Texas
Abstract

2023 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on cancer have been presented. According to news reporting from Houston, Texas, [...]

Published
2023

50. PDS Biotech to initiate phase 3 study evaluating PDS0101 in combo with keytruda in head and neck

Subjects
United States. Food and Drug Administration -- Planning, Merck & Company Inc. -- Planning, Biotechnology, Biotechnology industry -- Planning, Papillomavirus infections -- Care and treatment, Immunotherapy, Squamous cell carcinoma -- Care and treatment, Clinical trials, Company business planning, Pharmaceuticals and cosmetics industries, Keytruda (Medication)
Abstract

PDS Biotechnology Corporation, a clinical-stage immunotherapy company, announced that it has completed key tech transfer, scale up and manufacturing activities required to initiate a global, multicenter phase 3 registrational trial [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results